JCVI advice to mitigate impact of B1.617.2 variant

JCVI advises that every effort is made to promote vaccine uptake in those who remain unvaccinated in priority cohorts 1 to 9; and where vaccine supply allows, particularly in areas where B1.617.2 is major threat, 2nd dose of vaccine should be brought forward from 12 to 8 weeks.

Source:

Public Health England